PDF(2695 KB)
PDF(2695 KB)
PDF(2695 KB)
静脉用胺碘酮治疗血液透析并发严重快速性心律失常的临床疗效分析
Objective To investigate the effect of intravenous amiodarone on treating tachyarrythmia happened during hemodialysis. Methods Fifteen severe acute and chronic renal failure patients, including 6 male and 9 female, whose age averaged (55±21.5) years, occured tachyarrhythmia 22 times during hemodialysis. They were given introvenous amoiodarone for 50~100mg showly, then continuous intravenous drip for 100~150mg at the dose of 8~24μg/kg/min and repeated if necessary. The patients' symptoms, heartrate, cardiac rhythm and QT interphase were obserred and compared with 15 nondialysis controls. Results Thirteen times (59.1%) of the 22 tachy arrhythmia recovered sinus rhythm and the heart rates decreased to less than 100 pulse/min in 15 minutes, 6 times (27.3%) in 15~30 minutes and 3 times (13.6%) could not recover sinus rhythm in 30 minutes, but their heart rates decreased to 120~130 pulse/min and recovered sinus rhythm after supplementing potassium and intravenous injection of 0.2mg cedilanid. Patients' symptoms relieved quickly. There was no significont difference of QT interphase after therapy (P>0.05). One patient occured bradycardia and recovered after stopping amiodarone. There was no significant difference of therapy effect compared with the controls(P>0.05). Conclusions intravenous amiodarone is an effective and safe management of the serious tachyarry-thmia caused by hemodialysis.
/
| 〈 |
|
〉 |